` ALPHA (Pharnext SA) vs DAX Index Comparison - Alpha Spread

ALPHA
vs
D
DAX Index

Over the past 12 months, ALPHA has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +16% growth.

Stocks Performance
ALPHA vs DAX Index

Loading
ALPHA
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ALPHA vs DAX Index

Performance Gap Between ALPHA and GDAXI
HIDDEN
Show

Performance By Year
ALPHA vs DAX Index

Loading
ALPHA
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Pharnext SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Pharnext SA
Glance View

Market Cap
1.2k EUR
Industry
Biotechnology

Pharnext SA develops and manufactures drugs for neurological diseases. The company is headquartered in Issy-Les-Moulineaux, Ile-De-France. The company went IPO on 2016-07-18. The firm is focused on discovering, developing and licensing new therapeutic solutions (Pleodrugs) and companion tests for unmet medical needs (large and niche markets) by using the Pleotherapy approach. Pharnext SA runs all its own activities, from research through to clinical development (no further than the end of Phase II trials), and then licenses the Pleodrugs to industrial partners. The firm's prime focus is on neurodegenerative diseases and metabolic diseases.

ALPHA Intrinsic Value
Not Available
Back to Top